The average body surface area of adult cancer patients in the UK: a multicentre retrospective study
- PMID: 20126669
- PMCID: PMC2812484
- DOI: 10.1371/journal.pone.0008933
The average body surface area of adult cancer patients in the UK: a multicentre retrospective study
Abstract
The majority of chemotherapy drugs are dosed based on body surface area (BSA). No standard BSA values for patients being treated in the United Kingdom are available on which to base dose and cost calculations. We therefore retrospectively assessed the BSA of patients receiving chemotherapy treatment at three oncology centres in the UK between 1(st) January 2005 and 31(st) December 2005.A total of 3613 patients receiving chemotherapy for head and neck, ovarian, lung, upper GI/pancreas, breast or colorectal cancers were included. The overall mean BSA was 1.79 m(2) (95% CI 1.78-1.80) with a mean BSA for men of 1.91 m(2) (1.90-1.92) and 1.71 m(2) (1.70-1.72) for women. Results were consistent across the three centres. No significant differences were noted between treatment in the adjuvant or palliative setting in patients with breast or colorectal cancer. However, statistically significant, albeit small, differences were detected between some tumour groups.In view of the consistency of results between three geographically distinct UK cancer centres, we believe the results of this study may be generalised and used in future costings and budgeting for new chemotherapy agents in the UK.
Conflict of interest statement
Figures



Similar articles
-
Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA)>2 m2.Gynecol Oncol. 2009 Jul;114(1):53-6. doi: 10.1016/j.ygyno.2009.03.010. Epub 2009 Apr 8. Gynecol Oncol. 2009. PMID: 19359030
-
Body weight and body surface area of adult patients with selected cancers: An Italian multicenter study.PLoS One. 2024 Dec 17;19(12):e0314452. doi: 10.1371/journal.pone.0314452. eCollection 2024. PLoS One. 2024. PMID: 39689072 Free PMC article.
-
Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 study.Eur J Cancer. 2018 Aug;99:49-57. doi: 10.1016/j.ejca.2018.05.004. Epub 2018 Jun 15. Eur J Cancer. 2018. PMID: 29906734 Clinical Trial.
-
Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer.Cochrane Database Syst Rev. 2020 Jan 13;1(1):CD009256. doi: 10.1002/14651858.CD009256.pub3. Cochrane Database Syst Rev. 2020. PMID: 31930743 Free PMC article.
-
Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.Drugs R D. 2005;6(3):178-85. doi: 10.2165/00126839-200506030-00007. Drugs R D. 2005. PMID: 15869322 Review.
Cited by
-
Detecting and destroying cancer cells in more than one way with noble metals and different confinement properties on the nanoscale.Acc Chem Res. 2012 Nov 20;45(11):1854-65. doi: 10.1021/ar2003122. Epub 2012 Apr 30. Acc Chem Res. 2012. PMID: 22546051 Free PMC article.
-
Colorectal Cancer (CRC) treatment and associated costs in the public sector compared to the private sector in Johannesburg, South Africa.BMC Health Serv Res. 2020 Apr 7;20(1):290. doi: 10.1186/s12913-020-05112-w. BMC Health Serv Res. 2020. PMID: 32264964 Free PMC article.
-
Moderate mitral regurgitation accelerates left ventricular remodeling after posterolateral myocardial infarction.Ann Thorac Surg. 2011 Nov;92(5):1614-20. doi: 10.1016/j.athoracsur.2011.05.117. Epub 2011 Sep 25. Ann Thorac Surg. 2011. PMID: 21945222 Free PMC article.
-
Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction.Cochrane Database Syst Rev. 2016 Apr 29;4(4):CD005339. doi: 10.1002/14651858.CD005339.pub2. Cochrane Database Syst Rev. 2016. PMID: 27128488 Free PMC article.
-
Genome-wide conditional association study reveals the influences of lifestyle cofactors on genetic regulation of body surface area in MESA population.PLoS One. 2021 Jun 18;16(6):e0253167. doi: 10.1371/journal.pone.0253167. eCollection 2021. PLoS One. 2021. PMID: 34143809 Free PMC article.
References
-
- Kaestner SA, Sewell GJ. Chemotherapy dosing part I: scientific basis for current practice and use of body surface area. Clin Oncol (R Coll Radiol) 2007;19:23–37. - PubMed
-
- Dooley MJ, Singh S, Michael M. Implications of dose rounding of chemotherapy to the nearest vial size. Support Care Cancer. 2004;12:653–656. - PubMed
-
- Sawyer M, Ratain MJ. Body surface area as a determinant of pharmacokinetics and drug dosing. Invest New Drugs. 2001;19:171–177. - PubMed
-
- Undevia SD, Gomez-Abuin G, Ratain MJ. Pharmacokinetic variability of anticancer agents. Nat Rev Cancer. 2005;5:447–458. - PubMed
-
- Gurney H. Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative. J Clin Oncol. 1996;14:2590–2611. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources